• TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

  • Jul 4 2024
  • Duración: 36 m
  • Podcast

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • We love to hear from our listeners. Send us a message.

    KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Erin Harris to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have the potential to treat a variety of solid tumor types. Benson explains KSQ's Phase 1/2 clinical study, KSQ-001EX, which consists of TILs in which the SOCS1 gene is inactivated by CRISPR/Cas9 gene editing. In addition to solid tumors, Benson also addresses the therapeutic potential for autoimmune disease.
    Más Menos
activate_Holiday_promo_in_buybox_DT_T2
Más Menos

Lo que los oyentes dicen sobre TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles